Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric volume reduction via partial gastrectomy refers to a surgical procedure—most commonly the sleeve gastrectomy—in which a significant portion of the stomach is surgically removed. This results in a smaller gastric reservoir, directly restricting food intake and promoting early satiety. Beyond mechanical restriction, this intervention leads to complex physiological changes including reduced secretion of ghrelin (the hunger hormone), increased satiety hormones, altered gastrointestinal motility, shifts in gut microbiota composition, and changes in nutrient metabolism. These combined effects contribute not only to sustained weight loss but also improvement or remission of obesity-related comorbidities such as type 2 diabetes mellitus, hypertension, dyslipidemia, and obstructive sleep apnea. However, "gastric volume reduction via partial gastrectomy" is not itself a molecular target but rather describes a surgical technique; thus it does not fit standard definitions for therapeutic targets like receptors or enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric volume reduction via partial gastrectomy.